Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 11th June 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Changes to assessment of maximum residue limits
An MRL is the highest level of residue from a veterinary medicine that is legally allowed in food for human consumption.
New EMA measures to replace current guidance

Three new regulations to strengthen the assessment of maximum residue limits (MRLs) of veterinary medicines in food-producing animals have been implemented by the European Medicines Agency.

The measures will also serve as key reference documents for companies who apply for the establishment of MRLs for their respective medicine.

An MRL is the highest level of residue from a veterinary medicine that is legally allowed in food for human consumption. Under EU law, food from animals must not contain levels of veterinary medicine that might represent a hazard to the health of the consumer.

The first measure, adopted in January 2017, changes the structure of the documentation to be included in the application dossier for an MRL application by including a new chapter on risk management considerations. It also changes the position in the dossier of the so-called detailed and critical summaries - a summary report provided by experts.  

Measure two, adopted in May 2017, aims to increase the availability of veterinary medicines. It outlines the principles and minimum criteria for the extrapolation of an MRL to either another foodstuff from the same species, or to the same foodstuff from another species.

The third measure, adopted in May 2018, describes the methodology to be used in the scientific risk assessment and establishment of risk management recommendations relevant to MRL applications. The new rules will replace the existing guidance on MRLs in Volume 8 of “The rules governing medicinal products in the European Union" as of 19 June 2018. 

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.